Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis Resulting from Ovarian CancerAugust 26, 2019
Intraperitoneal hyperthermic chemotherapy (IPHC) is used as an adjunct to surgery for the treatment of gastrointestinal, appendiceal, ovarian, or mesothelial cancers that have metastasized or may metastasize into the peritoneal cavity. Chemotherapeutic drugs are introduced directly into the peritoneal space to eliminate microscopic tumor on the peritoneal lining and the outer surfaces of affected organs and to kill tumor cells that have disseminated throughout the cavity. Heating enhances the cytotoxic effect of the drugs.
If you have a Hayes login, click here to view the full report on the Knowledge Center.